Abstract
CDPamines are essential precursors for the biosynthesis de novo of phosphatidylcholine and phosphatidylethanolamine. The phosphoamine moiety is enzymically transferred to the diacylglycerol or other diradylglycerol by the choline or ethanolami ne specific phosphotransferase. As described in the following sections, CDPamines, especially CDPcholine, have been used to reverse increases in fatty acid levels following ischemia. CDPcholine has been used successfully to treat several types of central nervous system diseases including ischemia, Parkinson disease, cerebrovascular disease, senile dementia, and tardive dyskinesia. CDPcholine effects in these diseases may be related in part to its ability to increase dopamine levels.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aguilar J, Giménez R, Bachs O, Enrich C., Augt J (1983) Cerebral subcellular distribution of CDPcholine and/or its metabolites after oral administration of methyl-14C CDPcholine. Drug Res 33:1051–1053
Alberghina M, Viola M, Serra I, Mistretta A, Giuffrida AM (1981) Effect of CDP-choline on the biosynthesis of phospholipids in brain regions during hypoxic treatment. J Neurosci Res 6:421–433
Alemany S, Varela I, Harper JF, Mato JM (1982) Calmodulin regulation of phospholipid and fatty acid methylation by rat liver microsomes. J Biol Chem 257:9249–9251
Arranz J, Ganoza C (1983) Treatment of chronic dyskinesia with CDPcholine. Drug Res 33:1071–1073
Arrigoni E, Averet N, Cohadon F (1987) Effects of CDP-choline on phospholipase A2 and cholinephosphotransferase activities following a cryogenic brain injury in the rabbit. Biochem Pharmacol 36:3697–3700
Arthur G, Covic L, Wientzek M, Choy PC (1985) Plasmalogenase in hamster heart. Biochim Biophys Acta 833:189–195
Augt J, Font E, Sacristan A, Ortiz JA (1983a) Radioactivity incorporated into different cerebral phospholipids after oral administration of 14 C-methyl-CDPcholine. Drug Res 33:1048–1050
Augt J, Font E, Sacristan A, Ortiz JA (1983b) Dissimilar effects on acute toxicity studies of CDPcholine and choline. Drug Res 33:1016–1018
Augt J, Font E, Sacristan A, Ortiz JA (1983c) Bioavailability of methyl-14C-CDPcholine by oral route. Drug Res 33:1045–1047
Binaglia L, Roberti R, Corazzi L, Freysz L, Arienti G, Porcellati G (1985) Evidence for a compartmentation of the enzymes involved in CDPcholine metabolism at membrane level. In: Zappia V, Kennedy EP, Nilsson BI, Galletti P (eds) Novel Biochemical, Pharmacological and Clinical Aspects of Cytidinediphosphocholine. Elsevier, Amsterdam, p 131–136
Boismare F, Le Poncin M, Lefrancois J, Lecordier JC (1978) Action of cytidine diphosphocholine on functional and hemodynamic effects of cerebral ischemia in cats. Pharmacology 17:15–20
Burlina AP, Galzigna L (1989) Preparazione, proprietà e Potenzialità terapeutiche delia citidin-difosfocolina associata a liposomi. Rivista di Neurologia 59:26–31
Centrone G, Ragno G, Calicchio G (1986) Uso delia citicoline ad al ti dosaggi nelle affezioni acute cerebro-vascolari. Min Med 77:371–373
Ciaceri G (1985) Toxicological studies on CDPcholine. In: Zappia V, Kennedy EP, Nilsson BI, Galletti P (eds) Novel Biochemical, Pharmacological and Clinical Aspects of Cytidinediphosphocholine. Elsevier, Amsterdam, p 159–167
Clendenon NR, Palayoor ST, Gordon WA (1985) Influence of CDPcholine on ATPase activity in acute experimental spinal cord trauma. In: Zappia V, Kennedy EP, Nilsson BI, Galletii P (eds) Novel Biochemical, Pharmacological and Clinical Aspects of Cytidinediphosphocholine. Elsevier, Amsterdam, p 275–284
Cook HW, Vance DE (1985) Evaluation of possible mechanisms of phorbol ester stimulation of phosphatidylcholine synthesis in HeLa cells. Can J Biochem Cell Biol 63:145–151
Cubells JM, Hernando C (1988) Clinical trial on the use of cytidine diphosphate choline in Parkinson’s disease. Clin Thera 10:664–671
Damron DS, Dorman RV (1988) [3H]Arachidonic acid metabolism in rat brain minces: Effects of nucleotide triphosphates, CDPcholine and CMP. Neurochem Res 13:777–783
Demediuk P, Saunders RD, Anderson DK, Means ED, Horrocks LA (1985) Membrane lipid changes in laminectomized and traumatized cat spinal cord. Proc Natl Acad Sci USA 82:7071–7075
Dinsdale JRM, Griffiths GK, Castello J, Maddock J, Ortiz JA, Aylward M (1983a) CDPcholine: repeated oral dose tolerance studies in adult healthy volunteers. Drug Res 33:1061–1065
Dinsdale JRM, Griffiths GK, Rowlands C., Castello J, Ortiz JA, Maddock J, Aylward M (1983b) Pharmacokinetics of 14C CDPcholine. Drug Res 33:1066–1070
Dorman RV, Dabrowiecki Z, DeMedio GE, Porcellati G, Horrocks LA (1982) Effects of cytidine nucleotides on CNS membranes during ischemia. In: Grossman RG, Gildenberg PL (eds) Head Injury: Basic and Clinical Aspects. Raven Press, New York, p 93–101
Dorman RV, Dabrowiecki Z, Horrocks LA (1983) Effects of CDPcholine and CDPethanolamine on the alterations in rat brain lipid metabolism induced by global ischemia. J Neurochem 40:276–279
Eberhardt R, Birbamer G, Gerstenbrand F, Rainer E, Traegner H (1990) Citicoline in the treatment of Parkinson’s disease. Clin Thera 12:489–495
Fernandez RL (1983) Efficacy and safety of oral CDPcholine: drug surveillance study in 2817 cases. Drug Res 33:1073–1080
Freysz L, Golly F, Mykita S, Avola R, Dreyfus H, Massarelli R (1985) Metabolism of neuronal cell cultures: Modification induced by CDPcholine. In: Zappia V, Kennedy EP, Nilsson BI, Galletti P (eds) Novel Biochemical, Pharmacological and Clinical Aspects of Cytidinediphosphocholine. Elsevier, Amsterdam, p 117–129
Galletti P, De Rosa M, Nappi MA, Pontoni G, del Piano L, Salluzzo A, Zappia V (1985) Transport and metabolism of double-labelled CDPcholine in mammalian tissues. Biochem Pharmacol 34:4121–4130
Giraldi JP, Virno M, Covelli G, Grechi G, De Gregorio F (1989) Therapeutic value of citicoline in the treatment of glaucoma (computerized and automated perimetric investigation). Intl Ophthalm 13:109–112
Goldberg WJ, Dorman RV, Horrocks LA (1983) Effects of ischemia and diglycerides on ethanolamine and choline phosphotransferase activities from rat brain. Neurochem Pathol 1:225–234
Goldberg WJ, Dorman RV, Dabrowiecki Z, Horrocks LA (1985) The effects of ischemia and CDPamines on Na+,K+-ATPase and acetylcholinesterase activities in rat brain. Neurochem Pathol 3:237–248
Goracci G, Francescangeli E, Mozzi R, Porcellati S, Porcellati G (1985) Regulation of phospholipid metabolism by nucleotides in brain transport of CDPcholine into brain. In: Zappia V, Kennedy EP, Nilsson BI, Galletti P (eds) Novel Biochemical, Pharmacological and Clinical Aspects of Cytidinediphosphocholine. Elsevier, Amsterdam, p 105–116
Goracci G, Francescangeli E, Horrocks LA, Porcellati G (1986) A comparison of the reversibility of phosphoethanolamine transferase and phosphocholine transferase in rat brain microsomes. Biochim Biophys Acta 876:387–391
Grau T, Romero A, Sacristan A, Ortiz JA (1983) CDPcholine: acute toxicity study. Drug Res 33:1033–1034
Hamdorf G, Cervos-Navarre J (1990) Study of the effects of oral administration of CDPcholine on open-field behaviour under conditions of chronic hypoxia. Drug Res 40:519–522
Hatch GM, Choy PC (1990) Effect of hypoxia on phosphatidylcholine biosynthesis in the isolated hamster heart. Biochem J 268:47–54
Horrocks LA, Dorman RV (1985) Prevention by CDPcholine and CDPethanolamine of lipid changes during brain ischemia. In: Zappia V, Kennedy EP, Nilsson BI, Galletti P (eds) Novel Biochemical, Pharmacological and Clinical Aspects of Cytidinediphosphocholine. Elsevier, Amsterdam, p 205–215
Kakihana M, Fukuda N, Suno M, Nagaoka A (1988) Effects of CDP-choline on neurologic deficits and cerebral glucose metabolism in a rat model of cerebral ischemia. Stroke 19:217–222
Kanoh H, Ohno K (1973) Utilization of endogenous phospholipids by the backreaction of CDP-choline (-ethanolamine): 1,2-diglyceride choline (ethanolamine)-phosphotransferase in rat liver microsomes. Biochim Biophys Acta 306:203–217
Kanoh H, Ohno K (1975) Substrate-selectivity of rat liver microsomal 1,2-diacylglycerol: CDPcholine (ethanolamine) choline (ethanolamine) phosphotransferase in utilizing endogenous substrates. Biochim Biophys Acta 380:199–207
Mages F, Rey C., Fonlupt P, Pacheco H (1988) Kinetic and biochemical properties of CTP: choline-phosphate cytidylyltransferase from the rat brain. Eur J Biochem 178:367–372
Martinet M, Fonlupt P, Pacheco M (1978) Interaction of CDPcholine with synaptosomal transport of biogenic amines and their precursors in vitro and in vivo in the rat corpus striatum. Experientia 34:1197–1199
Masi I, Giani E, Galli C (1986) Effects of CDPcholine on platelet aggregation and the antiaggregatory activity of arterial wall in the rat. Pharm Res Commun 18:273–281
Morikawa S, Taniguchi S, Fujii K, Mori H, Kumada K, Fujiwara M (1987) Preferential synthesis of diacyl and alkenylacyl ethanolamine and choline glycerophospholipids in rabbit platelet membranes. J Biol Chem 262:1213–1217
Murphy EJ, Slivka AP, Horrocks LA (1991) Effect of methyl prednisolone and CDPcholine on ischemic infarct volume. Am Soc Neurochem 22:150(Abstract)
Ondera H, Iijima K, Kogure K (1986) Mononucleotide metabolism in the rat brain after transient ischemia. J Neurochem 46:1704–1710
Paddon HB, Vance DE (1980) Tetradecanoyl-phorbol acetate stimulates phosphatidylcholine biosynthesis in HeLa cells by an increase in the rate of the reaction catalyzed by CTP: phosphocholine cytidylyltransferase. Biochim Biophys Acta 620:636–640
Pelech SL, Pritchard PH, Vance DE (1981) cAMP analogues inhibit phosphatidylcholine biosynthesis in cultured rat hepatocytes. J Biol Chem 256:8283–8286
Petkov VD, Stancheva SL, Tocuschieva L, Petkov VV (1990) Changes in brain biogenic monoamines induced by the nootropic drugs adafenoxate and meclofenoxate and by citicholine (experiments on rats). Gen Pharmac 21:71–75
Possmayer F, Duwe G, Hahn M, Buchnea D (1977) Acyl specificity of CDPcholine: 1,2-diacylglycerol cholinephosphotransferase in rat lung. Can J Biochem 55:609–617
Radominska-Pyrek A, Strosznajder J, Dabrowiecki Z, Chojnacki T, Horrocks LA (1976) Effects of free fatty acids on the enzymic synthesis of diacyl and ether types of choline and ethanolamine phosphoglycerides. J Lipid Res 17:657–662
Romero A, Grau T, Sacristan A, Ortiz JA (1983a) Study of subacute toxicity of CDPcholine after 30 days of oral administration to rats. Drug Res 33:1035–1038
Romero A, Grau T, Sacristan A, Ortiz JA (1983b) CDPcholine: 6 month study on toxicity in dogs. Drug Res 33:1038–1042
Romero A, Serratosa J, Sacristan A, Ortiz JA (1983c) High resolution outerradiography in mouse brain 24 h after radiolabeled CDPcholine administration. Drug Res 33:1056–1058
Saligaut C., Daoust M, Moore N, Boismare F (1987) Effects of hypoxia and cytidine (5′) diphosphocholine on the concenrations of dopamine, norepinephrine and metabolites in rat hypothalamus and striatum. Arch Int Pharmacodyn 285:25–33
Sanghera JS, Vance DE (1989) Stimulation of CTP: phosphocholine cytidylyltransferase and phosphatidylcholine synthesis by calcium in rat hepatocytes. Biochim Biophys Acta 1003:284–292
Serra F, Diaspri GP, Gasbarrini A, Giancane S, Rimondi A, Tame MR, Sakellaridis E, Bernardi M, Gasbarrini G (1990) Effetto della CDPcolina sul decadimento mentale senile. Min Med 81:465–470
Sinforiani E, Trucco M, Pacchetti C., Gualtieri S (1986) Valutazione degli effetti delia citicolina nella malattia cerebro-vascolare cronica. Min Med 77:51–57
Taniguchi S, Morikawa S, Hayashi H, Fujii K, Mori H, Fujiwara M (1986) Effects of Ca2+ on ethanolaminephosphotransferase and cholinephosphotransferase in rabbit platelets. J Biochem 100:485–491
Tazaki Y, Sakai F, Otomo E, Kutsuzawa T, Kameyama M, Omae T, Fujishima M, Sakuma A (1988) Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study. Stroke 19:211–216
Trovarelli G, DeMedio GE, Montanini I (1982) The influence of CDP-choline on brain lipid metabolism during ischemia. II Farmaco 10:664–668
Weber G, Auteri A, Bianciardi G, Fabrini P, Resi L, Salvi M, Toti P, Tanganelli P (1989) Influence of CDPcholine administration on the aortic wall lesions in dietically hypercholesterolaemic rabbits: A morphometric evaluation. Drugs Exptl Clin Res 15:321–323
Woodard DS, Lee T-C, Snyder F (1987) The final step in the de novo biosynthesis of platelet-activating factor. J Biol Chem 262:2520–2527
Yamamoto M, Shimizu M, Okamiya H (1990) Pharmacological actions of the new TRH analogue, YM-14673, in rats subjected to cerebral ischemia and anoxia. Euro J Pharm 181:207–214
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Murphy, E.J., Horrocks, L.A. (1993). CDPcholine, CDPethanolamine, Lipid Metabolism and Disorders of the Central Nervous System. In: Massarelli, R., Horrocks, L.A., Kanfer, J.N., Löffelholz, K. (eds) Phospholipids and Signal Transmission. Nato ASI Series, vol 70. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-02922-0_28
Download citation
DOI: https://doi.org/10.1007/978-3-662-02922-0_28
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-02924-4
Online ISBN: 978-3-662-02922-0
eBook Packages: Springer Book Archive